STIM 0.75 (-57.87%)
US64131A1051Medical Diagnostics & ResearchDiagnostics & Research

Neuronetics (STIM) Competitor Comparison

We are evaluating the key criteria listed to compare Neuronetics (STIM) against its competitors in the Diagnostics & Research industry.

Performance 5 years - STIM ranking 51 / 58

These are the competitors of Neuronetics in the industry Diagnostics & Research ranked by performance 5 years
1. Medpace Holdings MEDP
389.62
2. RadNet RDNT
336.93
3. Lantheus Holdings LNTH
315.23
4. Natera NTRA
262.45
5. Fulgent Genetics FLGT
158.04
6. Meridian Bioscience VIVO
118.46
7. Danaher DHR
114.87
8. Thermo Fisher Scientific TMO
113.85
9. Icon ICLR
99.94
10. Agilent Technologies A
98.58
11. Mettler-Toledo MTD
96.45
12. DexCom DXCM
82.33
13. IDEXX Laboratories IDXX
75.94
14. DarioHealth DRIO
61.4
15. Laboratory Corp of America Holdings LH
60.3
16. Waters WAT
56.97
17. IQVIA Holdings IQV
51.05
18. Charles River Laboratories CRL
49.49
19. PerkinElmer PKI
48.44
20. Twist Bioscience TWST
48.2
21. Quest Diagnostics DGX
47.47
22. Trinity Biotech TRIB
30.15
23. Qiagen QGEN
23.12
24. Ortho Clinical Diagnostics Holdings OCDX
13.74
25. Heska HSKA
12.14
26. CareDx CDNA
0.15
27. Co-Diagnostics CODX
-11.81
28. Syneos Health SYNH
-16.98
29. Inotiv NOTV
-17.33
30. Olink Holding OLK
-26.82
31. Anixa Biosciences ANIX
-28.31
32. NeoGenomics NEO
-36.35
33. Myriad Genetics MYGN
-38.72
34. Sotera Health SHC
-46.11
35. Bioventus BVS
-49.74
36. Sera Prognostics SERA
-50.7
37. Exact Sciences EXAS
-52.24
38. Neogen NEOG
-52.82
39. Illumina ILMN
-58.61
40. National Research NRC
-67.25
41. Enzo Biochem ENZ
-71.35
42. Pacific Biosciences of California PACB
-72.4
43. Guardant Health GH
-72.53
44. MaxCyte MXCT
-75.4
45. MDxHealth MDXH
-78.68
46. bioAffinity Technologies BIAF
-78.81
47. Psychemedics PMD
-79.3
48. Exagen XGN
-79.88
49. Interpace Biosciences IDXG
-80.13
50. Personalis PSNL
-82.3
51. Neuronetics STIM
-82.43
52. Global Cord Blood CO
-86.47
53. Biodesix BDSX
-88.3
54. Precipio PRPO
-90.6
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-95.41

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.